Real-world experience with Ropeginterferon-alpha 2b (Besremi) in Philadelphia-negative myeloproliferative neoplasms

Huang, CE; Wu, YY; Hsu, CC; Chen, YJ; Tsou, HY; Li, CP; Lai, YH; Lu, CH; Chen, PT; Chen, CC

Chen, CC (corresponding author), Chang Gung Mem Hosp, Div Hematol & Oncol, Dept Med, Chiayi, Taiwan.

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2021; 120 (2): 863

Abstract

Background/purpose: Ropeginterferon alpha-2b (Ropeg) is a novel pegylated interferon-alpha recently approved for the treatment of polycythemia vera (P......

Full Text Link